Healthy women test new drug tablet – no cure, just science
NCT ID NCT06742086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a new tablet form of the drug venetoclax is absorbed in the body. 72 healthy women took the drug under different conditions (with or without high-fat food) to measure drug levels and side effects. The goal was to gather information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acpru /Id# 272979
Grayslake, Illinois, 60030, United States
-
PPD Phase I Clinic /ID# 275754
Austin, Texas, 78744, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?